Reviewing TAT Technologies (NASDAQ:TATT) & Mainz Biomed (NASDAQ:MYNZ)

Mainz Biomed (NASDAQ:MYNZ – Get Free Report) and TAT Technologies (NASDAQ:TATT – Get Free Report) are both small-cap industrials companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation.

Profitability

This table compares Mainz Biomed and TAT Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Mainz Biomed N/A N/A N/A
TAT Technologies 11.26% 9.84% 7.58%

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Mainz Biomed and TAT Technologies, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mainz Biomed 1 1 0 0 1.50
TAT Technologies 0 2 6 2 3.00

TAT Technologies has a consensus price target of $57.86, suggesting a potential upside of 74.79%. Given TAT Technologies’ stronger consensus rating and higher possible upside, analysts clearly believe TAT Technologies is more favorable than Mainz Biomed.

Risk and Volatility

Mainz Biomed has a beta of 0.31, meaning that its stock price is 69% less volatile than the S&P 500. Comparatively, TAT Technologies has a beta of 1.01, meaning that its stock price is 1% more volatile than the S&P 500.

Valuation & Earnings

This table compares Mainz Biomed and TAT Technologies”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Mainz Biomed $659,935.00 18.26 -$21.65 million ($65.60) -0.02
TAT Technologies $186.85 million 2.30 $16.82 million $1.60 20.69

TAT Technologies has higher revenue and earnings than Mainz Biomed. Mainz Biomed is trading at a lower price-to-earnings ratio than TAT Technologies, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

15.1% of TAT Technologies shares are owned by institutional investors. 18.2% of Mainz Biomed shares are owned by company insiders. Comparatively, 8.7% of TAT Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

TAT Technologies beats Mainz Biomed on 13 of the 15 factors compared between the two stocks.

About Mainz Biomed

(Get Free Report)

Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. The company was founded in 2008 and is based in Mainz, Germany.

About TAT Technologies

(Get Free Report)

TAT Technologies Ltd., together with its subsidiaries, provides solutions and services to the commercial and military aerospace, and ground defense industries in the United States, Israel, and internationally. The company operates through four segments: Original Equipment Manufacturing (OEM) of Heat Transfer Solutions and Aviation Accessories; Maintenance, Repair, and Overhaul (MRO) Services for Heat Transfer Components and OEM of Heat Transfer Solutions; MRO Services for Aviation Components; and Overhaul and Coating of Jet Engine Components. It designs, develops, and manufactures a range of heat transfer solutions, such as pre-cooler and oil/fuel hydraulic heat exchangers used in mechanical and electronic systems in commercial, military, and business aircraft; environmental control and power electronics cooling systems for use in aircraft and ground applications; and a range of other mechanical aircraft accessories and systems, such as pumps, valves, and turbine power units. The company provides MRO services for heat transfer components, as well as for manufacturing heat transfer solutions; and aviation components. In addition, it engages in the operation of a repair station, which provides heat transfer MRO services for airlines, air cargo carriers, maintenance service centers, and the military; and the overhaul and coating of jet engine components, including turbine vanes and blades, fan blades, variable inlet guide vanes, and afterburner flaps. The company was formerly known as Galagraph Ltd. and changed its name to TAT Technologies Ltd. in May 1992. TAT Technologies Ltd. was founded in 1969 and is headquartered in Netanya, Israel.

Receive News & Ratings for Mainz Biomed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mainz Biomed and related companies with MarketBeat.com's FREE daily email newsletter.